Azopharma Product Development Group plans to expand its clinical research management services through its newly formed company, Acromon Clinical Research Organization. This company adds to the services provided by the human clinical dosing unit, AvivoClin, and the bioanalytical services unit, ADMEQuant.      The new organization will provide clinical management services for human clinical trials. Acromon will operate independently from other Azopharma companies in order to design and monitor ...